Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-10-31

FDA Approved: BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE — Original Application (LGM PHARMA SOLUTIONS, LLC)

View source ↗

Summary

FDA approved a generic version of the combination analgesic butalbital, acetaminophen, and caffeine for headache indications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BUTALBITAL, ACETAMINOPHEN AND CAFFEINE (butalbital; acetaminophen; caffeine)

Snippet

ORIG AP for BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE (BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE)